FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities

Trends Immunol. 2015 Jun;36(6):325-36. doi: 10.1016/j.it.2015.04.005. Epub 2015 May 13.


Given the widespread use of antibodies of the immunoglobulin G (IgG) class as cytotoxic, immunomodulatory, and neutralizing agents in the therapy of malignant, infectious, and autoimmune diseases, understanding the molecular and cellular mechanisms responsible for their therapeutic activity is of major importance. While Fcγ receptors (FcγR) have well-appreciated roles as effectors of cytotoxic IgG activity, it has only recently become clear that the functionality of immunomodulatory and neutralizing IgG preparations also depends on cellular FcγRs. Here, we review current models of IgG activity in infectious and inflammatory settings, and examine the importance of cell type-specific expression of FcγRs in determining functional outcome. We discuss how this knowledge may be used to improve the activity of therapeutic antibody preparations and outline important areas of focus for future research.

Keywords: Fc receptor; agonistic antibody; cytotoxicity; immunoglobulin G; neutralizing antibody.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antibodies, Neutralizing / immunology*
  • Antibody-Dependent Cell Cytotoxicity / immunology*
  • Communicable Diseases / immunology
  • Humans
  • Immunoglobulin G / immunology*
  • Inflammation / immunology
  • Models, Immunological
  • Receptors, IgG / immunology*
  • T-Lymphocytes, Regulatory / immunology


  • Antibodies, Neutralizing
  • Immunoglobulin G
  • Receptors, IgG